ArticleScientific reports2025
Lactococcus lactis subsp. lactis as a biocontrol agent against phytopathogens causing rice bacterial leaf blight.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bacterial leaf blight (BLB) disease in rice caused by Xanthomonas oryzae pv. oryzae (Xoo) and Pantoea ananatis (Pan), is a widespread problem that results in substantial economic losses in rice-growing countries, including Malaysia. Farmers commonly rely on chemical controls to treat this disease, which are not safe for human health and the environment. Alternatively, Lactic acid bacteria (LAB) have gained attention for their potential in sustainable agricultural practices, benefitting human health and the environment. This study hypothesized that LAB, specifically Lactococcus lactis subsp. lactis (RBX7), have antimicrobial activity against phytopathogens, namely Xoo and Pan. The research aims to determine the antimicrobial activity of RBX7 and identify the antimicrobial compounds likely responsible for disease suppression. The antimicrobial cell-free supernatant (CFS) of RBX7 was obtained and tested for antimicrobial activity against Xoo and Pan using multiple methods, i.e. agar well diffusion, time-kill assays, detached leaf assays, and visualized using scanning electron microscopy (SEM). Metabolomic profiling was conducted to identify potential antimicrobial metabolites using LC-MS/MS-QTOF. Finally, the antibacterial effects of LAB were confirmed by in planta experiment. The detached leaf assay showed no lesions following inoculation with RBX7 live culture and RBX7 CFS, in line with the results from agar well diffusion assays. SEM analysis showed Pan cell rupture and Xoo cell shrinkage when treated with RBX7. Metabolomic analysis of RBX7 identified antimicrobial compounds such as cefixime, cinchonidine, antimycin A, and bufalin. Finally, in planta assays revealed that both RBX7 CFS and the live culture effectively suppressed BLB symptoms in rice seedlings. This study highlights a safer and more sustainable approach for controlling BLB in rice by utilizing RBX7 as a biocontrol agent, advancing efforts toward achieving sustainable development goals in rice farming.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.